Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our NAD+ provider ranking, above Breeze Meds at #3.
Read the Care Bare Rx review →Provider review
Names the exact compound in its nav — then hides the price behind a quiz.
Breeze Meds' navigation names Semaglutide Injection, Tirzepatide Injection, Oral Semaglutide and Oral Tirzepatide — four real, distinct products, not a vague "GLP-1" label. The homepage then gives you one number for all of them, "Starting at $199," and lets the intake quiz decide the rest.
Reviewed by Marcus Webb
Transparency scorecard
3 of 4 disclosed openly
What Breeze Meds discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
Ranked above it

Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our NAD+ provider ranking, above Breeze Meds at #3.
Read the Care Bare Rx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not confirmed
Prices read from Breeze Meds's own site · August 2026
What they advertise
"Starting at $199" for "Weight Loss Injections" on the homepage — the category entry point, before the quiz assigns you a compound.
What you actually pay
$199 a month is the only figure published anywhere on the site. There is no compound-specific price, and no prepay or auto-refill mechanism gating it. NAD+ injections start at $169, with no billing interval stated next to the figure.
Breeze Meds (breezemeds.com) names four distinct weight-loss products right in its navigation. Clinical care runs through "Lion MD," led by Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD, and its FAQ names four pharmacy partners with phone numbers — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx. That is the same clinical team and the same pharmacy network Care Bare Rx and Synergy Rx name, which makes all three storefronts for one operator. The states claim is clean and plain: "we service all 50 states." What holds it back is that the only price on the site is a category-wide "Starting at $199" sitting behind an intake quiz, and not one of the four named pharmacies is tied to a 503A or 503B category anywhere.
Breeze Meds appears on our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Breeze Meds does not name the pharmacy that fills your prescription.
Four pharmacies named outright in the FAQ, with phone numbers — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx. Neither "503A" nor "503B" appears anywhere on the site.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Clean and plain. The FAQ says, "We service all 50 states."
The part they would rather you skipped
Two of the four pharmacies Breeze Meds names — Belmar Pharma Solutions and Strive Pharmacy — carry FDA warning letters. Belmar: CMS Case #653740, March 31, 2023, over 503A violations, closed out 10/30/2023. Strive: letter #639220, August 29, 2022, closed out 05/28/2026. Neither disqualifies Breeze Meds, and several peers here carry the same kind of finding — but Breeze Meds names both pharmacies as active partners today, so both go on the record.
None of this is unique to Breeze Meds — the whole category shares it.
The providers we rank on our NAD+ provider ranking — the most specific board Breeze Meds sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.





45 more providers rank on our NAD+ provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Breeze Meds's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Breeze Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Breeze Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Breeze Meds
3 compounds, From $169